NEW YORK (GenomeWeb News) – Atossa Genetics on Thursday priced its initial public offering of 800,000 shares at $5 per share, raising gross proceeds of $4 million.
The Seattle-based firm granted its underwriter a 45-day option to purchase up to 120,000 shares to cover any overallotments. Atossa began trading on the Nasdaq Capital Market on Thursday under ticker symbol "ATOS." Its shares closed down 4 percent on Thursday at $4.80.
Dawson James Securities is the sole book-running manager on the offering.